We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+0.09%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.86B
AUM Growth
+$83M
Cap. Flow
+$153M
Cap. Flow %
2.62%
Top 10 Hldgs %
16.53%
Holding
808
New
59
Increased
345
Reduced
246
Closed
48

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$28.5M
2
LUV icon
Southwest Airlines
LUV
+$19.5M
3
MCHP icon
Microchip Technology
MCHP
+$17.7M
4
MSFT icon
Microsoft
MSFT
+$16.8M
5
LOW icon
Lowe's Companies
LOW
+$16.2M

Sector Composition

Rank Sector Weight
1 Healthcare 23.16%
2 Technology 15.94%
3 Financials 14.63%
4 Consumer Discretionary 10.42%
5 Communication Services 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIS icon
426
Fidelity National Information Services
FIS
$22.3B
$2.42M 0.04%
25,144
-1,338
-5% -$131K
ACHN
427
DELISTED
Achillion Pharmaceuticals
ACHN
$2.41M 0.04%
650,000
+215,000
+49% +$704K
MDRX
428
DELISTED
Veradigm Inc. Common Stock
MDRX
$2.41M 0.04%
195,000
APH icon
429
Amphenol
APH
$184B
$2.4M 0.04%
111,368
-3,596
-3% -$81K
HALO icon
430
Halozyme
HALO
$9.66B
$2.39M 0.04%
122,000
-14,000
-10% -$271K
IMVP
431
Invesco India ETF
IMVP
$124M
$2.39M 0.04%
95,000
+50,000
+111% +$1.31M
DOV icon
432
Dover
DOV
$27.7B
$2.38M 0.04%
30,066
+6,267
+26% +$514K
SRE icon
433
Sempra
SRE
$59.7B
$2.38M 0.04%
42,718
+5,786
+16% +$312K
GIL icon
434
Gildan
GIL
$9.38B
$2.37M 0.04%
82,250
-56,512
-41% -$1.75M
BN icon
435
Brookfield
BN
$103B
$2.36M 0.04%
169,635
-3,425
-2% -$49.6K
CF icon
436
CF Industries
CF
$18.4B
$2.35M 0.04%
62,428
+45,430
+267% +$1.85M
XLRN
437
DELISTED
Acceleron Pharma
XLRN
$2.35M 0.04%
60,000
-13,000
-18% -$553K
HLT icon
438
Hilton Worldwide
HLT
$75.3B
$2.34M 0.04%
29,734
+10,467
+54% +$859K
RHT
439
DELISTED
Red Hat Inc
RHT
$2.32M 0.04%
15,512
-544
-3% -$75.4K
GHDX
440
DELISTED
Genomic Health, Inc.
GHDX
$2.32M 0.04%
74,000
-15,000
-17% -$498K
LXRX icon
441
Lexicon Pharmaceuticals
LXRX
$991M
$2.3M 0.04%
268,000
TSM icon
442
TSMC
TSM
$2.07T
$2.29M 0.04%
52,500
+450
+0.9% +$19.6K
INDA icon
443
iShares MSCI India ETF
INDA
$6.77B
$2.29M 0.04%
67,000
+35,000
+109% +$1.24M
NFX
444
DELISTED
Newfield Exploration
NFX
$2.28M 0.04%
93,386
+10,074
+12% +$283K
RSG icon
445
Republic Services
RSG
$66.7B
$2.27M 0.04%
34,268
-3,421
-9% -$229K
CORI
446
DELISTED
Corium International, Inc.
CORI
$2.25M 0.04%
196,000
+110,000
+128% +$1.33M
S
447
DELISTED
Sprint Corporation
S
$2.25M 0.04%
460,042
-9,063
-2% -$48.4K
ALDR
448
DELISTED
Alder Biopharmaceuticals
ALDR
$2.23M 0.04%
176,000
+75,000
+74% +$1.08M
IEX icon
449
IDEX
IEX
$16.6B
$2.23M 0.04%
15,657
+1,762
+13% +$246K
PDCO
450
DELISTED
Patterson Companies, Inc.
PDCO
$2.23M 0.04%
+100,081
New +$3.11M

Similar funds

Candriam SCA's Q1 2018 Portfolio in Review

As of Q1 2018, Candriam SCA held 808 positions worth $5.86B, up 1.4% from $5.78B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA's Q1 2018 filing shows 59 new, 345 increased, 246 reduced and 48 closed positions. Its largest new stake was Ecopetrol: 700,000 shares worth $13.5M. The largest sale was Baidu, an estimated $28.5M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2018 buy was Ecopetrol: 700,000 shares worth $13.5M.
  • Candriam SCA added most to Biogen in Q1 2018, an estimated $50M increase.
  • Candriam SCA's biggest Q1 2018 reduction was Baidu, cutting an estimated $28.5M.
  • Candriam SCA fully exited Sociedad Química y Minera de Chile in Q1 2018, selling an estimated $13.4M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.86B portfolio in Q1 2018.
  • Candriam SCA opened 59 new positions and closed 48 in Q1 2018.
  • Candriam SCA's portfolio value rose 1.4% quarter-over-quarter to $5.86B.

Based on Candriam SCA's 13F filing for Q1 2018, filed 9 May 2018.